Clinical Trials Sponsored by FDA Orphan Products Division
Total 138 results
-
FDA Office of Orphan Products DevelopmentCompletedNeurofibromatosis 2United States
-
FDA Office of Orphan Products DevelopmentCompleted
-
FDA Office of Orphan Products DevelopmentCompleted
-
FDA Office of Orphan Products DevelopmentCompletedGuillain-Barre SyndromeUnited States
-
FDA Office of Orphan Products DevelopmentCompletedPneumonia | Bronchiolitis Obliterans | Respiratory Distress Syndrome, AdultUnited States
-
FDA Office of Orphan Products DevelopmentCompleted
-
FDA Office of Orphan Products DevelopmentCompletedCystic Fibrosis | Bacterial Infection
-
FDA Office of Orphan Products DevelopmentCompleted
-
FDA Office of Orphan Products DevelopmentCompletedMuscular DystrophiesUnited States
-
FDA Office of Orphan Products DevelopmentCompleted
-
FDA Office of Orphan Products DevelopmentCochlearCompleted
-
OrfagenFDA Office of Orphan Products DevelopmentCompletedCongenital Venous MalformationUnited States, France
-
FDA Office of Orphan Products DevelopmentBezoloven, Inc.WithdrawnVitamin D Deficiency | Lead PoisoningUnited States
-
FDA Office of Orphan Products DevelopmentDuke UniversityCompletedLambert-Eaton Myasthenic Syndrome
-
FDA Office of Orphan Products DevelopmentDuke UniversityCompletedMyasthenia Gravis
-
Georgetown UniversityCompletedEnd Stage Renal Disease | HyperhomocysteinemiaUnited States
-
FDA Office of Orphan Products DevelopmentVanderbilt UniversityCompletedKidney Failure, ChronicUnited States
-
FDA Office of Orphan Products DevelopmentCuris, Inc.Unknown
-
Mayo ClinicTerminated
-
TVAX BiomedicalFDA Office of Orphan Products DevelopmentRecruitingGlioblastoma Multiforme of BrainUnited States
-
Jazz PharmaceuticalsFDA Office of Orphan Products DevelopmentCompletedSevere Hepatic Veno-Occlusive DiseaseUnited States, Canada
-
Emory UniversityTerminated
-
Columbia UniversityCompletedOsteoporosisUnited States
-
Northwestern UniversityTerminated
-
Point TherapeuticsCompletedChronic Lymphocytic LeukemiaUnited States
-
Columbia UniversityFDA Office of Orphan Products DevelopmentRecruiting
-
FDA Office of Orphan Products DevelopmentCentocor, Inc.Completed
-
Emory UniversityCompletedGlioblastoma Multiforme | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Recurrent Brain Tumor | Mixed Gliomas
-
Mayo ClinicCompletedMyocarditisUnited States
-
Cellegy PharmaceuticalsCompleted
-
FDA Office of Orphan Products DevelopmentSciClone PharmaceuticalsCompleted
-
United TherapeuticsCompletedPulmonary HypertensionUnited States
-
Boston Children's HospitalFDA Office of Orphan Products DevelopmentActive, not recruiting
-
Aegerion Pharmaceuticals, Inc.FDA Office of Orphan Products DevelopmentCompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, South Africa
-
University of ChicagoCompleted
-
University of FloridaCompleted
-
National Jewish HealthCompletedMycobacterium Avium-intracellulare Infection
-
Johns Hopkins UniversityCompletedCerebral HemorrhageUnited States
-
University of MichiganCompletedGraft Versus Host DiseaseUnited States
-
University of TexasTerminated
-
University of TexasCompletedAcute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia
-
University of PittsburghCompletedTrigeminal NeuralgiaUnited States
-
Holles Laboratories, Inc.Completed
-
University of VermontCompleted
-
University of TexasCompletedEsophageal Achalasia
-
NeuroHealing Pharmaceuticals Inc.FDA Office of Orphan Products DevelopmentSuspended
-
University of PittsburghCompletedSezary Syndrome | Cutaneous T-cell LymphomaUnited States
-
FDA Office of Orphan Products DevelopmentUniversity of UtahCompleted
-
University of ChicagoCompleted
-
University of IowaCompletedLymphatic MalformationsUnited States